Technology

Kaleido Biosciences

$12.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.40 (+3.32%) Today
+$0.18 (+1.44%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KLDO and other stocks, options, and ETFs commission-free!

About KLDO

Kaleido Biosciences, Inc. engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. It offers microbiome metabolic therapies (MMT) which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA. The listed name for KLDO is Kaleido Biosciences, Inc. Common Stock.

CEO
Daniel L. Menichella
Employees
91
Headquarters
Lexington, Massachusetts
Founded
2015
Market Cap
469.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
160.49K
High Today
$12.70
Low Today
$11.74
Open Price
$12.00
Volume
134.29K
52 Week High
$14.44
52 Week Low
$2.82

Collections

KLDO Earnings

-$0.89
-$0.59
-$0.30
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 1, Pre-Market

You May Also Like

SKHSY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure